Mark H. Watson

2.7k total citations
26 papers, 2.1k citations indexed

About

Mark H. Watson is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Mark H. Watson has authored 26 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 7 papers in Cell Biology and 5 papers in Oncology. Recurrent topics in Mark H. Watson's work include Ubiquitin and proteasome pathways (5 papers), Microtubule and mitosis dynamics (4 papers) and Cancer-related Molecular Pathways (4 papers). Mark H. Watson is often cited by papers focused on Ubiquitin and proteasome pathways (5 papers), Microtubule and mitosis dynamics (4 papers) and Cancer-related Molecular Pathways (4 papers). Mark H. Watson collaborates with scholars based in United States, Canada and France. Mark H. Watson's co-authors include Steven I. Reed, Alan S. Mak, Jiing-Dwan Lee, Richard I. Tapping, Yutaka Kato, Richard J. Ulevitch, Shuang Huang, Duncan J. Clarke, Bonnie L. Bertolaet and Gilles Divita and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Mark H. Watson

26 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark H. Watson United States 18 1.8k 611 586 185 135 26 2.1k
Tai-An Lin United States 17 2.2k 1.2× 285 0.5× 371 0.6× 163 0.9× 104 0.8× 20 2.9k
Frank McCormick United States 16 2.6k 1.5× 902 1.5× 486 0.8× 185 1.0× 199 1.5× 29 3.3k
William A. Barton United States 19 1.4k 0.8× 267 0.4× 406 0.7× 109 0.6× 70 0.5× 26 2.1k
Sarang Kulkarni Canada 19 2.8k 1.6× 285 0.5× 960 1.6× 190 1.0× 64 0.5× 20 3.5k
Jorrit M. Enserink Norway 23 2.0k 1.1× 379 0.6× 411 0.7× 84 0.5× 87 0.6× 57 2.6k
Liliana B. Areces Italy 18 1.7k 0.9× 416 0.7× 908 1.5× 53 0.3× 51 0.4× 22 2.3k
Craig W. Vander Kooi United States 29 1.4k 0.8× 452 0.7× 320 0.5× 150 0.8× 78 0.6× 67 2.2k
Rajat Gupta Denmark 14 1.8k 1.0× 326 0.5× 412 0.7× 70 0.4× 192 1.4× 15 2.2k
Ken‐ichi Kariya Japan 31 1.9k 1.1× 182 0.3× 520 0.9× 320 1.7× 220 1.6× 58 2.7k
Bo Zhai United States 25 2.4k 1.4× 370 0.6× 541 0.9× 67 0.4× 291 2.2× 29 2.9k

Countries citing papers authored by Mark H. Watson

Since Specialization
Citations

This map shows the geographic impact of Mark H. Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark H. Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark H. Watson more than expected).

Fields of papers citing papers by Mark H. Watson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark H. Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark H. Watson. The network helps show where Mark H. Watson may publish in the future.

Co-authorship network of co-authors of Mark H. Watson

This figure shows the co-authorship network connecting the top 25 collaborators of Mark H. Watson. A scholar is included among the top collaborators of Mark H. Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark H. Watson. Mark H. Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Libiger, Ondrej, Leslie M. Shaw, Mark H. Watson, et al.. (2021). Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease. Alzheimer s & Dementia. 17(12). 1976–1987. 55 indexed citations
2.
Barra, Carolina, Chloé Ackaert, Birkir Reynisson, et al.. (2020). Immunopeptidomic Data Integration to Artificial Neural Networks Enhances Protein-Drug Immunogenicity Prediction. Frontiers in Immunology. 11. 1304–1304. 21 indexed citations
3.
Beauparlant, Pierre, Dominique Bédard, Cynthia Bernier, et al.. (2009). Preclinical development of the nicotinamide phosphoribosyl transferase inhibitor prodrug GMX1777. Anti-Cancer Drugs. 20(5). 346–354. 51 indexed citations
4.
Roulston, Anne, Mark H. Watson, Cynthia Bernier, et al.. (2007). GMX1777: a novel inhibitor of NAD+ biosynthesis via inhibition of nicotinamide phosphoribosyl transferase.. Molecular Cancer Therapeutics. 6. 2 indexed citations
5.
Morris, May C., et al.. (2003). Cks1-dependent proteasome recruitment and activation of CDC20 transcription in budding yeast. Nature. 423(6943). 1009–1013. 105 indexed citations
6.
Bertolaet, Bonnie L., Duncan J. Clarke, Mark H. Watson, et al.. (2001). UBA domains mediate protein-protein interactions between two DNA damage-inducible proteins 1 1Edited by M. Yaniv. Journal of Molecular Biology. 313(5). 955–963. 96 indexed citations
7.
Spruck, Charles, Heimo Strohmaier, Mark H. Watson, et al.. (2001). A CDK-Independent Function of Mammalian Cks1. Molecular Cell. 7(3). 639–650. 318 indexed citations
8.
9.
Kaiser, Peter, Vincent Moncollin, Duncan J. Clarke, et al.. (1999). Cyclin-dependent kinase and Cks/Suc1 interact with the proteasome in yeast to control proteolysis of M-phase targets. Genes & Development. 13(9). 1190–1202. 72 indexed citations
10.
Kato, Yutaka, Richard I. Tapping, Shuang Huang, et al.. (1998). Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor. Nature. 395(6703). 713–716. 386 indexed citations
11.
Bourne, Yves, Mark H. Watson, Michael J. Hickey, et al.. (1996). Crystal Structure and Mutational Analysis of the Human CDK2 Kinase Complex with Cell Cycle–Regulatory Protein CksHs1. Cell. 84(6). 863–874. 213 indexed citations
12.
Watson, Mark H., Yves Bourne, A.S. Arvai, et al.. (1996). A Mutation in the Human Cyclin-dependent Kinase Interacting Protein, CksHs2, Interferes With Cyclin-dependent Kinase Binding and Biological Function, but Preserves Protein Structure and Assembly. Journal of Molecular Biology. 261(5). 646–657. 13 indexed citations
13.
Tsuruda, Toshihiro, Mark H. Watson, D. Brian Foster, J J Lin, & Alan S. Mak. (1995). Alignment of caldesmon on the actin-tropomyosin filaments. Biochemical Journal. 309(3). 951–957. 14 indexed citations
14.
Mezl, Vasek A., Mark H. Watson, T. Geoffrey Flynn, & Alan S. Mak. (1994). Phosphorylation of the precursor sequence of rat B-type natriuretic peptide by p34cdc2 and MAP kinase. Biochemistry and Cell Biology. 72(5-6). 227–232. 3 indexed citations
15.
Venance, Shannon L., Mark H. Watson, Dennis A. Wigle, Alan S. Mak, & Stephen C. Pang. (1993). Differential expression and activity of p34cdc2 in cultured aortic adventitial fibroblasts derived from spontaneously hypertensive and Wistar???Kyoto rats. Journal of Hypertension. 11(5). 483–490. 11 indexed citations
16.
Childs, Timothy, Mark H. Watson, Robert E. Novy, Jim Jung‐Ching Lin, & Alan S. Mak. (1992). Calponin and tropomyosin interactions. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1121(1-2). 41–46. 36 indexed citations
17.
Mak, Alan S., et al.. (1991). Phosphorylation of caldesmon by cdc2 kinase.. Journal of Biological Chemistry. 266(11). 6678–6681. 58 indexed citations
18.
Watson, Mark H., et al.. (1990). Caldesmon, calmodulin and tropomyosin interactions. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1054(1). 103–113. 17 indexed citations
19.
Watson, Mark H., et al.. (1990). Caldesmon-binding sites on tropomyosin.. Journal of Biological Chemistry. 265(31). 18860–18866. 38 indexed citations
20.
Watson, Mark H., Ashok K. Taneja, Robert S. Hodges, & Alan S. Mak. (1988). Phosphorylation of .alpha..alpha.- and .beta..beta.-tropomyosin and synthetic peptide analogs. Biochemistry. 27(12). 4506–4512. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tai-An Lin Breakdown of academic impact, for papers by Frank McCormick Breakdown of academic impact, for papers by William A. Barton Breakdown of academic impact, for papers by Sarang Kulkarni Breakdown of academic impact, for papers by Jorrit M. Enserink Breakdown of academic impact, for papers by Liliana B. Areces Breakdown of academic impact, for papers by Craig W. Vander Kooi Breakdown of academic impact, for papers by Rajat Gupta Breakdown of academic impact, for papers by Ken‐ichi Kariya Breakdown of academic impact, for papers by Bo Zhai
Rankless by CCL
2026